Concepedia
Statistics
Publications
10
Citations
680
H-Index
Active since
1991
Affiliations
University of Connecticut(Current)
Knopp Biosciences (United States)
Massachusetts General Hospital
Neurobehavioral Systems
Biogen (United States)
Evan W. Ingersoll is an author at University of Connecticut specializing in medicine, care of premature infants, and infant health.
Publications per year
1991–2016
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Merit Cudkowicz, Leonard H. van den Berg, Jeremy M. Shefner et al. · The Lancet Neurology · 2013 · 235 citations
Medicine, Neurology, Pharmacology +8
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
Merit Cudkowicz, Michael Bozik, Evan W. Ingersoll et al. · Nature Medicine · 2011 · 179 citations
Life Sciences, Neuroscience, Pharmacology +11
Sleep/Wake States of Preterm Infants: Stability, Developmental Change, Diurnal Variation, and Relation with Caregiving Activity
Evelyn B. Thoman, Evan W. Ingersoll · Child Development · 1999 · 68 citations
Medicine, Human Development, Pediatrics +17
Safety, Tolerability, and Pharmacokinetics of KNS-760704 (Dexpramipexole) in Healthy Adult Subjects
Michael Bozik, James Mather, William G. Kramer et al. · The Journal of Clinical Pharmacology · 2010 · 41 citations
Medicine, Pharmacokinetics, Pharmacology +15
The breathing bear: Effects on respiration in premature infants
Evan W. Ingersoll, Evelyn B. Thoman · Physiology & Behavior · 1994 · 31 citations
Life Sciences, Pediatrics, Physiology +12
1–5 of 10